Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Goode

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Science (New York, N.Y.)|June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancerArcadi Cipponi, David L Goode, Justin Bedo, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
Nature Communications|June 22, 2019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C Bell, Katie A Fennell, Yih-Chih Chan, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Science (New York, N.Y.)|June 6, 2020
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancerArcadi Cipponi, David L Goode, Justin Bedo, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
The Lancet. Oncology|August 9, 2016
Monogenic and polygenic determinants of sarcoma risk: an international genetic studyMandy L Ballinger, David L Goode, Isabelle Ray-Coquard, et al.
Nature Communications|June 22, 2019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C Bell, Katie A Fennell, Yih-Chih Chan, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 4